Data / Form D filings / SEMBIOSYS GENETICS INC
SEMBIOSYS GENETICS INC: Form D filings
SEMBIOSYS GENETICS INC, a biotechnology company in Calgary, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on March 26, 2010, reports $88,651 sold of a $88,651 offering to 2 investors.
Find out what SEMBIOSYS GENETICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- #110, 2985 - 23rd Avenue NE, Calgary, T1Y7L
- Phone
- (403) 250-5424
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Year incorporated
- 2009
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1128323
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2010 | New notice | $88,651 | $88,651 | $0 | 2 | Mar 12, 2010 | sec.gov |
| Mar 31, 2009 | New notice | $43,501 | $43,501 | $0 | 2 | Mar 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Smith | Director | |
| Alexander Giaquinto | Director | |
| Ian Brown | Director | |
| William Smith | Director | |
| James Szarko | Director, Executive Officer | |
| Oye Olukotun | Director |
Every Form D from the week of Mar 22, 2010 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SEMBIOSYS GENETICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.